Members News

25/11/2020    Meet Scendea at 5 forthcoming events including Biotech Showcase...more

20/11/2020    BIA launches report on rare disease medicines appraisal...more

19/11/2020    Worldwide Clinical Trials appoints new Senior VP, Oncology...more

18/11/2020    Covid-19 industry response provides major boost to Welsh economy...more

17/11/2020    SEKISUI Diagnostics Announces Launch of the OSOM® Flu Test in Europe...more

17/11/2020    Almac Group awarded grant from COVID-19 Therapeutics Accelerator...more

16/11/2020    Silence Therapeutics Presents Positive Pre-Clinical Data for SLN360...more

15/11/2020    Arcinova appoints Kelly Rhys-Jones as Human Resources Director...more

12/11/2020    Sareum Issues Update on SRA737 Licensing Agreement...more

18/11/2020    Barrington James Medical Spotlight on Medical Affairs...more

10/11/2020    Benefit from Bionow's Kickstart Scheme...more

04/11/2020    Precision Medicine nominated for Best CRO by OBN Awards...more

02/11/2020    Silence Therapeutics Appoints new Senior VP, Molecular Design...more


Members News Archive


Albumedix
Alderley Park
Almac Group
Almac Discovery
Amphista Therapeutics
Aptus Clinical
Arcinova
Astex Pharmaceuticals
Barrington James
BIA
Bionow
BioPartner UK
bit bio
Cello Health Consulting
Curileum Discovery
ERA Consulting
Eurofins Selcia Drug Discovery
Fusion Antibodies
IDACO Consulting
Intract Pharma
Isogenica
Karma Oncology
Mawdsleys
Medherant
MediWales
MGB Biopharma
Mironid
OBN (UK)
OFX
Oncimmune
One Nucleus
Oppilotech
Oxford Biomedica
Oxstem
Parkinson's Concierge
Pebmond Associates
Pneumagen
Precision For Medicine
Sareum
Scendea
Sekisui Diagnostics
Shift Bioscience
Silence Therapeutics
Sphere Fluidics
Sygnature Discovery
SYNthesis Research and SYNthesis Med Chem
Worldwide Clinical Trials
XenoGesis


Members - send your news for inclusion!
Non-members - join here!
Not listed? renew your lapsed membership here!


BioPartner is an accredited trade organisation (ATO) subject to terms and conditions. Any claims to discounts, offers and invitations are subject to availability.

Accredited by



Partners

Scottish Development International